You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Respiratory Drugs During Breastfeeding

Breastfeeding Medicine

Impact Factor: 1.8 / 5-Year Impact Factor: 2.2

Journal Homepage Submission guidelines

Restricted access

Research article

First published online November, 2019

Respiratory Drugs During Breastfeeding

Volume 14, Issue 9

https://doi.org/10.1089/bfm.2019.0194

Abstract

Get full access to this article

View all access options for this article.

References

1.

Eglash

A

. Treatment of maternal hypergalactia. Breastfeed Med, 2014; 9:423–425.

2.

Leon

SL

, Kaufman

DG

, Howard

M

, et al. Safety outcomes among infants exposed to omalizumab via breastfeeding: Results from the Xolair Pregnancy Registry (Expect). Pharmacoepidemiol Drug Saf, 2019; 28 (Suppl 2):374–375. Abstract.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Parathyroid Hormone-Related Protein in Preterm Human Milk

Retricted access

ABM Presidency Farewell: Breastfeeding Medicine Clarion Call

Retricted access

Breastfeeding Protects Against Type 1 Diabetes Mellitus: A Case–Sibling Study

Retricted access

A Perspective from Indian Health Service—Supporting Breastfeeding